SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 22, 2003
BRISTOL-MYERS SQUIBB COMPANY
(Exact Name of Registrant as Specified in its Charter)
Delaware (State or Other Jurisdiction of Incorporation) |
1-1136 (Commission File Number) |
22-079-0350 (IRS Employer Identification Number) |
345 Park Avenue
New York, NY 10154
(Address of Principal Executive Office)
Registrant's telephone number, including area code: (212) 546-4000
On July 22, 2003, Bristol-Myers Squibb Company issued a press release, announcing the recent initiation of an internal review of sales and marketing practices, a copy of which is attached as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
EXHIBIT NO. |
DESCRIPTION |
|
---|---|---|
99.1 | Press Release dated July 22, 2003 of Bristol-Myers Squibb Company |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Bristol-Myers Squibb Company, |
|||
By: |
/s/ SANDRA LEUNG Name: Sandra Leung Title: Secretary |
Date: July 23, 2003
3
EXHIBIT NO. |
DESCRIPTION |
|
---|---|---|
99.1 | Press Release dated July 22, 2003 of Bristol-Myers Squibb Company |